±3,4-Methylenedioxymethamphetamine: Treating PTSD in The Modern World: A Groundbreaking Methodology for Spiritual Wellness and Neuroplasticity
Item
-
Title
-
±3,4-Methylenedioxymethamphetamine: Treating PTSD in The Modern World: A Groundbreaking Methodology for Spiritual Wellness and Neuroplasticity
-
Author
-
Ashley A. Baxter
-
Date
-
26 May 2016
-
Type
-
Text; Image; StillImage
-
Identifier
-
aes/90
-
Language
-
eng
-
Abstract
-
Post-traumatic stress disorder (PTSD) is a serious condition that afflicts millions of individuals in the United States. Its complexity has resulted in physicians struggling to effectively implement and maintain treatment. Emerging studies suggest that ±3,4-Methylenedioxymethamphetamine (MDMA), or “ecstasy”, may prove beneficial in treating PTSD in combination with conventional psychotherapy. By acting on the 5-HT transporter in the brain, MDMA has been found to have positive effects on brain activity; encouraging neuroplasticity through the accumulation of brain-derived neurotrophic factor (BDNF). Integrating psychoactive drugs into polytrauma therapy will broaden our understanding of the components involved in maintaining wellness in the human psyche.
-
Description
-
This presentation was delivered on May 25, 2017 at Western Oregon University Academic Excellence Showcase (Monmouth).
-
Rights
-
Western Oregon University Library has determined, as of 06/20/2018, this item is in copyright, which is held by the author(s). Users may use the item in accordance with copyright limitations and exceptions, including fair use. For other uses, please ask permission from the author(s).
-
http://rightsstatements.org/vocab/InC/1.0/
-
Department
-
Health/Exercise Science
-
Faculty Sponsor
-
Warren Allen
Powerpoint File